Sugen, Inc.
🏢 View company profile →167Patents
4Active
167Granted
41Portfolio score
Filing activity: Jan 7, 1994 → Sep 11, 2008 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5792783A | 3-heteroaryl-2-indolinone compounds for the treatment of disease | Chemistry; Metallurgy | 254 | Expired |
| US5883113A | 3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease | Chemistry; Metallurgy | 169 | Expired |
| US5886020A | 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease | Chemistry; Metallurgy | 168 | Expired |
| US5834504A | 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease | Chemistry; Metallurgy | 165 | Expired |
| US6326469A | Megakaryocytic protein tyrosine kinases | Chemistry; Metallurgy | 121 | Expired |
| US5883116A | 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease | Chemistry; Metallurgy | 114 | Expired |
| US5804396A | Assay for agents active in proliferative disorders | Physics | 112 | Expired |
| US5650415A | Quinoline compounds | Human Necessities | 103 | Expired |
| US5789427A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 95 | Expired |
| US5773476A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 85 | Expired |
| US5763198A | Screening assays for compounds | Physics | 84 | Expired |
| US5792771A | Quinazoline compounds and compositions thereof for the treatment of disease | Physics | 82 | Expired |
| US6331555A | Treatment of platelet derived growth factor related disorders such as cancers | Human Necessities | 81 | Expired |
| US5700823A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 76 | Expired |
| US5942385A | Method for molecular diagnosis of tumor angiogenesis and metastasis | Chemistry; Metallurgy | 74 | Expired |
| US6133305A | 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity | Chemistry; Metallurgy | 74 | Expired |
| US6573293B2 | Pyrrole substituted 2-indolinone protein kinase inhibitors | Chemistry; Metallurgy | 70 | Expired |
| US6841579B1 | Diagnosis and treatment of AUR1 and/or AUR2 related disorders | Physics | 65 | Expired |
| US5712395A | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis | Physics | 64 | Expired |
| US5773459A | Urea- and thiourea-type compounds | Chemistry; Metallurgy | 61 | Expired |
| US5880141A | Benzylidene-Z-indoline compounds for the treatment of disease | Chemistry; Metallurgy | 61 | Expired |
| US6316635A | 2-indolinone derivatives as modulators of protein kinase activity | Chemistry; Metallurgy | 56 | Expired |
| US5763441A | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis | Physics | 53 | Expired |
| US6506763B2 | 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity | Chemistry; Metallurgy | 50 | Expired |
| US5990141A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 47 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.